Small Cap Shares Moleculin Biotech Inc. MBRX, + 3.77% A 43% surge in pre-market trade Tuesday, after the company said a second round of laboratory tests confirmed antiviral activity for WP1122, its candidate for treatment for COVID-19. The laboratory involved was the IIT Research Institute, an affiliate of the Illinois …
Read More »
Networking site LinkedIn is cutting around 960 jobs, or 6% of its workforce, as it moves to align business with the new world COVID-19. In a message posted on the website of the Microsoft Corp.-owned company, Chief Executive Ryan Roslanksy said LinkedIn is not immune to the effects of the …
Read More »
Shares of Amazon.com Inc. AMZN, + 7.93% rose 6.2% in afternoon trade, to add $ 91.3 billion to the cloud and e-commerce giant’s market capitalization, after MKM Partners analyst Rohit Kulkarni raised his price target by a 33% citing the company as a dual beneficiary of the COVID-19 pandemic. Amazon’s …
Read More »
Shares of AstraZeneca AZN, -0.75% AZN + 3.16% They fell 3.4% in trade on Monday after a medical journal published a study that found the company’s COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a phase 1/2 clinical trial. . AstraZeneca is developing the experimental vaccine with …
Read More »
BioNTech BNTX Shares, + 3.95% and Pfizer Inc. PFE, + 1.46% Both were launched into pre-market trade on Monday after companies said their experimental COVID-19 vaccine elicited a T-cell response in people participating in a phase 1/2 clinical trial in Germany. The vaccine candidate also again demonstrated that it can …
Read More »